For more information on specific business or products, please get in touch with us at
General Enquiries: neopharma@neopharma.com
Business Development / Partnerships: bd@neopharma.com
Neopharma
Plot A-1 89-95,
Industrial City of
Abu Dhabi
(ICAD), Mussafah,Abu Dhabi,
United Arab Emirates.
Tel:+971-025501000
Neopharma Inc.
Subsidiary of Neopharma
116 Village Blvd Suite 200
Forrestal Village,
Princeton, NJ, 08540,
USA
Tel: +14257727407
Sauad Farmaceutica
Subsidiary of Neopharma
Rod GO 010 km 32, Sitio do
Sobradinho, Zona Rural, Bonfinopolis,
Goias, Brazil, CEP 75195-000.
Tel: +55 62 3334-1698
Neopharma Russia
Subsidiary of Neopharma
Building 1, Office 207,
Street 65, Profsouznaya,
Moscow,
Russia 117342
Omnicare Drugs India Pvt. Ltd.
Subsidiary of Neopharma
Office 401,
Manjeera Trinity Corporate,
JNTU,
Kukatpally, Hyderabad,
Telangana, India-500072
Tel: +914067818000
Neopharma Japan Co. Ltd
Subsidiary of Neopharma
Iidabashi Grand Bloom,
4th Floor, Fujimi 2-10-2
Chiyoda-ku,
Tokyo 102-0071
Tel: +0120-392-750
Pharmaline Inc
Subsidiary of Neopharma
Unit 5
2835 Argentia Road,
Mississauga On,
Canada L5N 8G6
Tel: +19058123916
Patient health and safety is of foremost concern for all our healthcare products. In order to continuously monitor and for the assessment of the benefit-risk ratio of our medicines, we encourage you all to report any adverse events that occurs due to the usage of our products.
You can report an adverse event in the following ways:
Toll Free Number: 80003110058
Fax: +971 43970941
Email: neopharma.pv@neopharma.com